Good post. I can't disagree that timely product placement is very important now that medical cannabis has crossed the threshold from limited to mass public acceptance and California, once alone, has plenty of company. The sooner the patients can learn about Dharmanol (and why it is unique) and other MG/BB products on tap the better. Media is interested, but they can't report on what they can't see in the medical cannabis space.